These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9331441)

  • 1. Effect of body weight on aminoglycoside pharmacokinetics in patients with hypoalbuminemia.
    Kale-Pradhan PB; Buckler V; Bush PW
    Am J Health Syst Pharm; 1997 Oct; 54(19):2201-3. PubMed ID: 9331441
    [No Abstract]   [Full Text] [Related]  

  • 2. Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.
    Etzel JV; Nafziger AN; Bertino JS
    Antimicrob Agents Chemother; 1992 Mar; 36(3):679-81. PubMed ID: 1622185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in aminoglycoside pharmacokinetics in patients with cancer.
    Higa GM; Murray WE
    Clin Pharm; 1987 Dec; 6(12):963-6. PubMed ID: 3427879
    [No Abstract]   [Full Text] [Related]  

  • 4. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration.
    Chuk AC; Saeed F; Kousar N; Burrill S; Barns B; Rickrode G; Fu J; Katrych O; Saunders-Hao P; Block C; Lahey T
    Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
    Alghanem S; Paterson I; Touw DJ; Thomson AH
    J Antimicrob Chemother; 2013 Jun; 68(6):1338-47. PubMed ID: 23435691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
    Matthews I; Kirkpatrick C; Holford N
    Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in aminoglycoside volume of distribution in patients below ideal body weight.
    Tointon MM; Job ML; Peltier TT; Murphy JE; Ward ES
    Clin Pharm; 1987 Feb; 6(2):160-2. PubMed ID: 3665369
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients.
    Chelluri L; Warren J; Jastremski MS
    Chest; 1989 Jun; 95(6):1295-7. PubMed ID: 2721269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin pharmacokinetics in Native Americans of Apache ancestry.
    Murphy JE; Severnak T
    Am J Health Syst Pharm; 1996 Sep; 53(18):2189-91. PubMed ID: 8879327
    [No Abstract]   [Full Text] [Related]  

  • 11. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
    Bookstaver PB; Johnson JW; McCoy TP; Stewart D; Williamson JC
    Ann Pharmacother; 2008 Dec; 42(12):1758-65. PubMed ID: 19047358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin.
    Zantvoort FA; Wagenvoort JH; Derkx FH; Michel MF
    Br J Clin Pharmacol; 1987 Oct; 24(4):511-8. PubMed ID: 3689631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More on variability in aminoglycoside volume of distribution.
    Dasta JF; Armstrong DK
    Clin Pharm; 1987 Mar; 6(3):193. PubMed ID: 3665376
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
    Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
    Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics.
    Welch LP; Leader WG; Chandler MH
    Clin Pharm; 1993 Dec; 12(12):909-13. PubMed ID: 8137608
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration.
    Breilh D; Allaouchiche B; Jaumain H; Boulétreau P; Chassard D; Malbec I; Ducint D; Saux MC
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2409-11. PubMed ID: 10508016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.